A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used prescription drugs was revived by a federal appeals ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
However, beverages and alcohol stocks have held steady amidst all this with share prices up 2.8% on average since the latest earnings results ... Coca-Cola reported revenues of $12.31 billion, up 2.9% ...